We are live on ! Find out more
GTCM

Gyon Technologies Capital Management Portfolio holdings

AUM $267M
1-Year Est. Return 11.62%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
-11.62%
3 Year Est. Return
+42.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$65.9M
Cap. Flow
+$67.5M
Cap. Flow %
18.18%
Top 10 Hldgs %
12.07%
Holding
522
New
181
Increased
107
Reduced
74
Closed
160

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.22M
2
TJX icon
TJX Companies
TJX
+$4.48M
3
AZN icon
AstraZeneca
AZN
+$4.01M
4
CNI icon
Canadian National Railway
CNI
+$3.93M
5
DE icon
Deere & Co
DE
+$3.88M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.51M
2
PYPL icon
PayPal
PYPL
+$3.48M
3
AYI icon
Acuity Brands
AYI
+$3.39M
4
PFE icon
Pfizer
PFE
+$3.35M
5
META icon
Meta Platforms (Facebook)
META
+$2.98M

Sector Composition

Rank Sector Weight
1 Financials 23.31%
2 Technology 18.47%
3 Healthcare 15.14%
4 Industrials 12.83%
5 Consumer Discretionary 12.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
376
Biogen
BIIB
$30.5B
– –
-8,458
Closed -$2.93M
BIO icon
377
Bio-Rad Laboratories Class A
BIO
$9.16B
– –
-314
Closed -$202K
BNY
378
Bank of New York Mellon
BNY
$108B
– –
-4,867
Closed -$249K
BP icon
379
BP
BP
$109B
– –
-16,024
Closed -$423K
CAH icon
380
Cardinal Health
CAH
$55.7B
– –
-11,086
Closed -$633K
CAT icon
381
Caterpillar
CAT
$395B
– –
-3,327
Closed -$724K
CB icon
382
Chubb
CB
$137B
– –
-15,438
Closed -$2.45M
CCJ icon
383
Cameco
CCJ
$40.8B
– –
-50,865
Closed -$976K
CCK icon
384
Crown Holdings
CCK
$13.2B
– –
-6,596
Closed -$674K
CF icon
385
CF Industries
CF
$17.9B
– –
-9,815
Closed -$505K
CHD icon
386
Church & Dwight Co
CHD
$24.5B
– –
-3,176
Closed -$271K
CME icon
387
CME Group
CME
$95B
– –
-1,528
Closed -$325K
CMG icon
388
Chipotle Mexican Grill
CMG
$42.7B
– –
-16,450
Closed -$510K
CNC icon
389
Centene
CNC
$31.7B
– –
-4,761
Closed -$347K
COLD icon
390
Americold
COLD
$4.11B
– –
-7,438
Closed -$282K
CPRI icon
391
Capri Holdings
CPRI
$1.72B
– –
-7,278
Closed -$416K
CRL icon
392
Charles River Laboratories
CRL
$12.8B
– –
-1,915
Closed -$708K
CROX icon
393
Crocs
CROX
$6.43B
– –
-2,967
Closed -$346K
CTRA
394
DELISTED
Coterra Energy
CTRA
– –
-51,304
Closed -$896K
CVLT icon
395
Commault Systems
CVLT
$5.53B
– –
-6,816
Closed -$533K
CXT icon
396
Crane NXT
CXT
$3.13B
– –
-9,668
Closed -$310K
CZR icon
397
Caesars Entertainment
CZR
$6.12B
– –
-20,815
Closed -$2.16M
DD icon
398
DuPont de Nemours
DD
$19.5B
– –
-2,158
Closed -$210K
DG icon
399
Dollar General
DG
$28.1B
– –
-2,525
Closed -$546K
DGX icon
400
Quest Diagnostics
DGX
$26.3B
– –
-3,809
Closed -$503K
14 15
16
17 18

Similar funds

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACMV
August Capital Management VII Palo Alto, California $265M AUM 26.86% 1-Year Est. Return
SCM
Stormborn Capital Management Greenwich, Connecticut $263M AUM 8.83% 1-Year Est. Return
RW
Reframe Wealth Fairfax, Virginia $260M AUM
A
Accenture Dublin, Ireland $254M AUM 59.98% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
JW
Jenkins Wealth Englewood, Colorado $249M AUM
APP
Alpha Paradigm Partners Chicago, Illinois $242M AUM 9.65% 1-Year Est. Return

Gyon Technologies Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Gyon Technologies Capital Management held 522 positions worth $371M, up 22% from $305M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Gyon Technologies Capital Management deployed $67.5M of net new capital in Q3 2021, opening 181 new positions and adding to 107 existing holdings. Its largest new stake was AstraZeneca: 34,466 shares worth $4.14M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $3.35M trimmed.

  • Gyon Technologies Capital Management's largest Q3 2021 buy was AstraZeneca: 34,466 shares worth $4.14M.
  • Gyon Technologies Capital Management added most to Microsoft in Q3 2021, an estimated $5.22M increase.
  • Gyon Technologies Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.35M.
  • Gyon Technologies Capital Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $3.51M.
  • Gyon Technologies Capital Management's ten largest holdings make up 12% of its $371M portfolio in Q3 2021.
  • Gyon Technologies Capital Management opened 181 new positions and closed 160 in Q3 2021.
  • Gyon Technologies Capital Management's portfolio value rose 22% quarter-over-quarter to $371M.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.